Plain-English translation of NCT05582876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a specialized imaging scan called 68Ga-PSMA-11 PET/MR can help doctors better plan treatment for prostate cancer. The scan combines two types of imaging to create detailed pictures of the prostate and surrounding areas. Researchers want to see if this imaging helps doctors choose the right treatment plan for patients with newly diagnosed prostate cancer or those whose cancer has returned after initial treatment.
Current imaging methods may miss some cancer or not show the full picture of where cancer has spread, which can affect treatment decisions. This trial is testing whether this newer imaging technique gives doctors better information to personalize treatment plans and improve outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a specialized imaging scan called a PET/MR scan using the radiotracer 68Ga-PSMA-11. This involves receiving an injection of a small amount of radioactive tracer, then lying in a scanner for detailed pictures of your prostate and nearby areas. The images help your doctors understand where cancer may be located so they can create a personalized treatment plan. The scan itself typically takes less than an hour, and you will be able to go home the same day.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Poland